Pharsight

OSE IMMUNOTHERAPEUTICS SA PATENTS FACING OPPOSITIONS

Top patents of OSE IMMUNOTHERAPEUTICS SA facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3209691B1 15 Jul, 2020 Compositions for inducing differentiation of myeloid derived suppressor cell to treat cancer and infectious diseases Oct, 2035 1